Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Stokes

Showing results (661-670 of 678) with videos related to

Pageof 68
Sort By:
Bioorganic & Medicinal Chemistry Letters|November 30, 2013
Design, synthesis and structure-activity relationships of substituted oxazole-benzamide antibacterial inhibitors of FtsZNeil R Stokes, Nicola Baker, James M Bennett, et al.
NPJ Vaccines|July 29, 2022
Mucosal administration of a live attenuated recombinant COVID-19 vaccine protects nonhuman primates from SARS-CoV-2Mariana F Tioni, Robert Jordan, Angie Silva Pena, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 9, 2021
Targeting In Vivo Metabolic Vulnerabilities of Th2 and Th17 Cells Reduces Airway InflammationDiana C Contreras Healey, Jacqueline Y Cephus, Sierra M Barone, et al.
Cell Host & Microbe|September 26, 2017
Dietary Manganese Promotes Staphylococcal Infection of the HeartLillian J Juttukonda, Evelien T M Berends, Joseph P Zackular, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 16, 2025
Evaluating the Impact of the COVID-19 Pandemic on Pediatric Asthma IncidenceAshley L Devonshire, Theresa Guilbert, Cindy S Bauer, et al.
RSC Medicinal Chemistry|June 7, 2021
Rational design, synthesis and testing of novel tricyclic topoisomerase inhibitors for the treatment of bacterial infections part 2R Kirk, A Ratcliffe, G Noonan, et al.
RSC Medicinal Chemistry|June 7, 2021
Rational design, synthesis and testing of novel tricyclic topoisomerase inhibitors for the treatment of bacterial infections part 1R Kirk, A Ratcliffe, G Noonan, et al.
Bioorganic & Medicinal Chemistry Letters|March 1, 2022
Discovery and structure-activity relationships of a novel oxazolidinone class of bacterial type II topoisomerase inhibitorsAmanda Lyons, James Kirkham, Kevin Blades, et al.
Bioorganic & Medicinal Chemistry Letters|August 4, 2014
Discovery and in vivo evaluation of alcohol-containing benzothiazoles as potent dual-targeting bacterial DNA supercoiling inhibitorsJames T Palmer, Lorraine C Axford, Stephanie Barker, et al.
Mucosal Immunology|February 23, 2025
Interleukin-10 production by innate lymphoid cells restricts intestinal inflammation in miceJing Li, Justin Jacobse, Jennifer M Pilat, et al.
Pageof 68

Showing results (661-670 of 678) with videos related to

Sort By:
Pageof 68
Bioorganic & Medicinal Chemistry Letters|November 30, 2013
Design, synthesis and structure-activity relationships of substituted oxazole-benzamide antibacterial inhibitors of FtsZNeil R Stokes, Nicola Baker, James M Bennett, et al.
NPJ Vaccines|July 29, 2022
Mucosal administration of a live attenuated recombinant COVID-19 vaccine protects nonhuman primates from SARS-CoV-2Mariana F Tioni, Robert Jordan, Angie Silva Pena, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 9, 2021
Targeting In Vivo Metabolic Vulnerabilities of Th2 and Th17 Cells Reduces Airway InflammationDiana C Contreras Healey, Jacqueline Y Cephus, Sierra M Barone, et al.
Cell Host & Microbe|September 26, 2017
Dietary Manganese Promotes Staphylococcal Infection of the HeartLillian J Juttukonda, Evelien T M Berends, Joseph P Zackular, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 16, 2025
Evaluating the Impact of the COVID-19 Pandemic on Pediatric Asthma IncidenceAshley L Devonshire, Theresa Guilbert, Cindy S Bauer, et al.
RSC Medicinal Chemistry|June 7, 2021
Rational design, synthesis and testing of novel tricyclic topoisomerase inhibitors for the treatment of bacterial infections part 2R Kirk, A Ratcliffe, G Noonan, et al.
RSC Medicinal Chemistry|June 7, 2021
Rational design, synthesis and testing of novel tricyclic topoisomerase inhibitors for the treatment of bacterial infections part 1R Kirk, A Ratcliffe, G Noonan, et al.
Bioorganic & Medicinal Chemistry Letters|March 1, 2022
Discovery and structure-activity relationships of a novel oxazolidinone class of bacterial type II topoisomerase inhibitorsAmanda Lyons, James Kirkham, Kevin Blades, et al.
Bioorganic & Medicinal Chemistry Letters|August 4, 2014
Discovery and in vivo evaluation of alcohol-containing benzothiazoles as potent dual-targeting bacterial DNA supercoiling inhibitorsJames T Palmer, Lorraine C Axford, Stephanie Barker, et al.
Mucosal Immunology|February 23, 2025
Interleukin-10 production by innate lymphoid cells restricts intestinal inflammation in miceJing Li, Justin Jacobse, Jennifer M Pilat, et al.
Pageof 68